Contrast-Enhanced MRI Texture Parameters as Potential Prognostic Factors for Primary Central Nervous System Lymphoma Patients Receiving High-Dose Methotrexate-Based Chemotherapy

Table 1

Characteristics of patients diagnosed with PCNSL.

Characteristics	Numbers	value
Age	58.45 (range: 32∼75)	0.210
<60 years old	36 (69.2%)
>60 years old	16 (30.8%)
Gender		0.372
Male	29 (55.8%)
Female	23 (44.2%)
Surgery		0.684
Stereotactic biopsy (STB)	35 (57.7%)
Subtotal resections (STRs)	17 (13.5%)
Chemotherapy
High-dose MTX-based chemotherapy regimen	49 (94.2%)
R-CHOP+MTX chemotherapy regimen	3 (5.8%)
Radiotherapy		0.032
Yes	11 (21.2%)
No	41 (78.8%)
Patient survival status
Dead	18 (mean time: 22 months)
Alive	34